Hoffman Michael B

CIK 000129020810 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001290208

Recent Transactions

50 trades

Purchase
Annovis Bio, Inc.$ANVS
Common Stock
2025-12-08$4.24/sh+15,000→ 2,574,739 total
Purchase
Annovis Bio, Inc.$ANVS
Common Stock
2025-12-08$4.34/sh+30,000→ 2,559,739 total
Purchase
Annovis Bio, Inc.$ANVS
Common Stock
2025-11-24$3.85/sh+9,200→ 2,491,228 total
Purchase
Annovis Bio, Inc.$ANVS
Common Stock
2025-11-24$4.13/sh+1,489→ 2,492,028 total
Purchase
Annovis Bio, Inc.$ANVS
Common Stock
2025-11-24$4.15/sh+28,096→ 2,519,739 total
Purchase
Annovis Bio, Inc.$ANVS
Common Stock
2025-11-24$4.14/sh+415→ 2,501,643 total
Purchase
Annovis Bio, Inc.$ANVS
Common Stock
2025-11-24$4.14/sh+415→ 2,491,643 total
Purchase
Annovis Bio, Inc.$ANVS
Common Stock
2025-11-24$3.85/sh+9,200→ 2,501,228 total
Purchase
Annovis Bio, Inc.$ANVS
Common Stock
2025-11-24$4.13/sh+1,489→ 2,482,028 total
Purchase
Annovis Bio, Inc.$ANVS
Common Stock
2025-11-24$4.15/sh+28,096→ 2,529,739 total
Purchase
Annovis Bio, Inc.$ANVS
Common Stock
2025-11-21$3.49/sh+10,000→ 2,480,539 total
Purchase
Annovis Bio, Inc.$ANVS
Common Stock
2025-11-21$3.50/sh+10,000→ 2,490,539 total
Purchase
Annovis Bio, Inc.$ANVS
Common Stock
2025-11-14$2.11/sh+15,000→ 2,470,539 total
Purchase
Annovis Bio, Inc.$ANVS
Common Stock
2025-10-28$2.05/sh+975,610→ 2,455,539 total
Award
Annovis Bio, Inc.$ANVS
Common Stock
2025-08-29$2.28/sh+5,000→ 1,469,929 total
Award
Annovis Bio, Inc.$ANVS
Common Stock
2025-08-29$2.30/sh+5,000→ 1,479,929 total
Award
Annovis Bio, Inc.$ANVS
Common Stock
2025-08-29$2.29/sh+5,000→ 1,474,929 total
Award
Annovis Bio, Inc.$ANVS
Common Stock
2025-08-19$2.57/sh+1,100→ 1,464,929 total
Award
Annovis Bio, Inc.$ANVS
Common Stock
2025-08-19$2.59/sh+5,283→ 1,458,284 total
Award
Annovis Bio, Inc.$ANVS
Common Stock
2025-08-19$2.60/sh+6,717→ 1,453,001 total
Award
Annovis Bio, Inc.$ANVS
Common Stock
2025-08-19$2.58/sh+5,545→ 1,463,829 total
Award
Annovis Bio, Inc.$ANVS
Common Stock
2025-06-13$2.80/sh+25,000→ 1,446,283 total
Award
Annovis Bio, Inc.$ANVS
Common Stock
2025-06-13$2.83/sh+1→ 1,446,284 total
Award
Annovis Bio, Inc.$ANVS
Common Stock
2025-05-29$2.43/sh+5,000→ 1,421,283 total
Award
Annovis Bio, Inc.$ANVS
Common Stock
2023-11-20$6.07/sh+164,745→ 224,222 total
Award
Annovis Bio, Inc.$ANVS
Common Stock
2023-11-20$6.10/sh+163,880→ 223,357 total
Award
Annovis Bio, Inc.$ANVS
Stock Option (right to buy)
2023-11-17+29,600→ 29,600 total
Award
Annovis Bio, Inc.$ANVS
Common Stock
2023-04-07$12.61/sh+59,477→ 59,477 total
Award
Annovis Bio, Inc.$ANVS
Stock Option (right to buy)
2023-01-18+6,820→ 6,820 total
Tax Payment
Annovis Bio, Inc.$ANVS
Common Stock
2022-01-04$19.78/sh−90→ 1,416,283 total
Exercise/Conversion
Annovis Bio, Inc.$ANVS
Stock Option (right to buy)
2022-01-04−7,142→ 0 total
Exercise/Conversion
Annovis Bio, Inc.$ANVS
Common Stock
2022-01-04$4.39/sh+30,000→ 1,415,889 total
Tax Payment
Annovis Bio, Inc.$ANVS
Common Stock
2022-01-04$19.78/sh−6,658→ 1,409,231 total
Exercise/Conversion
Annovis Bio, Inc.$ANVS
Common Stock
2022-01-04$0.25/sh+7,142→ 1,416,373 total
Exercise/Conversion
Annovis Bio, Inc.$ANVS
Stock Option (right to buy)
2022-01-04−30,000→ 0 total
Award
Annovis Bio, Inc.$ANVS
Stock Option (right to buy)
2022-01-03+9,000→ 9,000 total
Award
Annovis Bio, Inc.$ANVS
Stock Option (right to buy)
2021-07-07+4,500→ 4,500 total
Sale
Traws Pharma, Inc.$TRAW
Common Stock
2020-08-27$0.27/sh−1,876→ 0 total
Sale
Traws Pharma, Inc.$TRAW
Common Stock
2020-08-27$0.27/sh−182,492→ 21,919 total
Award
Traws Pharma, Inc.$TRAW
Stock Appreciation Right
2020-07-09+125,000→ 125,000 total
Award
Annovis Bio, Inc.$ANVS
Stock Option (right to buy)
2020-07-01+30,000→ 30,000 total
Conversion
Annovis Bio, Inc.$ANVS
Common Stock
2020-01-31$4.80/sh+55,884→ 1,400,175 total
Purchase
Annovis Bio, Inc.$ANVS
Common Stock
2020-01-31$6.00/sh+33,333→ 47,619 total
Conversion
Annovis Bio, Inc.$ANVS
Series A Preferred Stock
2020-01-31−1,593,118→ 0 total
Conversion
Annovis Bio, Inc.$ANVS
Convertible Note
2020-01-31$4.80/sh−55,884→ 0 total
Conversion
Annovis Bio, Inc.$ANVS
Series A-1 Preferred Stock
2020-01-31−222,222→ 0 total
Conversion
Annovis Bio, Inc.$ANVS
Common Stock
2020-01-31+1,137,942→ 1,344,291 total
Conversion
Annovis Bio, Inc.$ANVS
Common Stock
2020-01-31+158,730→ 206,349 total
Award
Traws Pharma, Inc.$TRAW
Stock Option (right to purchase)
2019-07-26+5,833→ 5,833 total
Sale
Traws Pharma, Inc.$TRAW
Common Stock
2018-08-29$0.45/sh−29,999.262→ 5,731,116.738 total

Companies

Recent Filings

Address

712 FIFTH AVENUE, 51ST FLOOR

NEW YORK, NY, 10019

View on SEC.gov